The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease

Eur J Pharmacol. 2024 Apr 12:176586. doi: 10.1016/j.ejphar.2024.176586. Online ahead of print.ABSTRACTCoronary atherosclerotic heart disease (CHD) is a primary cardiovascular disease caused by atherosclerosis (AS), which is characterized by chronic inflammation and lipid oxidative deposition. Molecular hydrogen (H2) is an effective anti-inflammatory agent and has potential to ameliorate glycolipid metabolism disorders, which is believed to exert beneficial effects on the prevention and treatment of CHD. It is suggested that H2 reduces inflammation in CHD by regulating multiple pathways, including NF-κB inflammatory pathway, pyroptosis, mitophagy, endoplasmic reticulum (ER) stress, and Nrf2 antioxidant pathway. Additionally, H2 may improve glycolipid metabolism by mediation of PI3K and AMPK signalling pathways, contributing to inhibition of the occurrence and development of CHD. This review elaborates pathogenesis of CHD and evaluates the role of H2 in CHD. Moreover, possible molecular mechanisms have been discussed and speculated, aiming to provide more strategies and directions for subsequent studies of H2 in CHD.PMID:38615891 | DOI:10.1016/j.ejphar.2024.176586
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research